DOCSLIB.ORG

Jan 19, 2009 Listing of Generic, Non

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Jan 19, 2009 Listing of Generic, Non http://www.medword.com/uspa.html Jan 19, 2009 Listing of generic, non-prescription, prescription, and OTC (over-the-counter) p harmaceuticals A-200 Gel Concentrate A-200 Shampoo Concentrate A-25 A-Cillin A-Fil A-Hydrocort A-methaPred A-Phedrin A-Spas S/L A Plus A.C. & C. A.P.L. A.R.M. Allergy Relief A.R.M. Maximum Strength Caplets A/B Otic A/Fish Oil A/T/S abacavir abarelix-depot-F abarelix-depot-M Abbokinase Abbokinase Open-Cath Abelcet Abenol Abitrate Absorbine Athletes Foot Absorbine Jock Itch Absorbine Jr. Antifungal AC acarbose Accolate Accupep HPF Accupril Accuretic Accutane Accutane Roche acebutolol Acel-Imune Acellular DTP Aceon Acet-2 Acet-3 Acet Codeine 30 Acet Codeine 60 Aceta Aceta Elixir Aceta Tablets acetaminophen acetaminophen-butalbital acetaminophen-caffeine acetaminophen-chlorpheniramine acetaminophen-codeine acetaminophen-dextromethorphan acetaminophen-diphenhydramine acetaminophen-hydrocodone acetaminophen-oxycodone acetaminophen-phenyltoloxamine acetaminophen-propoxyphene acetaminophen-propoxyphene hydrochloride acetaminophen-propoxyphene napsylate acetaminophen-pseudoephedrine acetazolam acetazolamide Acetest acetic acid Acetocot acetohexamide acetophenazine Acetoxyl 10 Gel Acetoxyl 2.5 Gel Acetoxyl 20 Gel Acetoxyl 5 Gel acetylsalicylic acid Achromycin Achromycin V aciclovir Acid Control Acid Phos Fluor Rinse Acilac Aciphex acitretin Aclophen Aclovate Acne-10 Lotion Acne-5 Lotion Acne-Aid Aqua Gel Acne-Aid Gel Acne-Aid Vanishing Cream Acne Aid 10 Cream Acne Lotion 10 Acne Prone Skin Sunscreen Acne Wash Acno Acnomel Acne Cream Acnomel B.P. 5 Lotion Acnomel Cake Acnomel Cream Acnomel Vanishing Cream Acnotex Acolysis acrivastine acrivastine-pseudoephedrine Act Act-B12 Act-HIB ACT Fluoride Rinse Actagen Actagen-C Cough Actamin Actamin Extra Actamin Super Actibine Acticin Acticort 100 Actidose-Aqua Actidose with Sorbitol Actifed Actifed Allergy Day/Night Actifed Allergy Nighttime Caplets Actifed Cold Actifed Cold & Sinus Actifed Cold & Sinus Caplets Actifed Cold And Sinus Actifed Cough Actifed DM Actifed Plus Actifed Plus Extra Strength Caplets Actifed Sinus Day Actifed Sinus Day and Night Actifed Sinus Daytime Actifed Sinus Daytime Caplets Actifed Sinus Nighttime Actifed Sinus Nighttime Caplets Actifed w/ codeine Cough Actigall Actimmune Actimol Chewable Tablets Actimol Children's Suspension Actimol Infants' Suspension Actimol Junior Strength Caplets Actinex Actinomycin-D Actiprofen Caplets Actiq Actisite Activase Activase RT-PA activated charcoal Activella Actonel Actos Actron Acular Acuprin 81 Acutrim 16-Hour Acutrim II Maximum Strength Acutrim Late Day Acycloguanosine acyclovir acyclovir topical Adagen Adalat Adalat CC Adalat PA Adalat XL adapalene topical Adapin AdatoSil 5000 Adderall Adeflor Adgan Adipex-P Adipost Adlone-40 Adlone-80 Adrenalin Adrenalin Chloride Adrenalin Chloride Solution Adrenaline Adrenocot Adrenocot L.A. Adriamycin PFS Adriamycin RDF Adrucil adsorbocarpine Advair Advair diskus Advance Advanced Formula Di-Gel Advantage Advera Advil Advil Caplets Advil Children's Advil Cold Advil Cold and Sinus Advil Cold and Sinus Caplets Advil Junior Strength Advil Liquigel Advil Migraine Advil Pediatric AeroBid AeroBid-M Aerolate III Aerolate JR Aerolate SR Aeroseb-Dex Aeroseb-HC Afko-Lube Afko-Lube Lax Afrin Afrin Cherry 12-Hour Nasal Spray Afrin Cherry Scented Nasal Spray Afrin Children's Strength Nose Drops Afrin Extra Moisturizing 12-Hour Nasal Spray Afrin Extra Moisturizing Nasal Decongestant Spray Afrin Menthol Nasal Spray Afrin Nasal Sinus Afrin Nasal Spray Afrin Nose Drops Afrin Original 12-Hour Nasal Spray Afrin Original 12-Hour Nose Drops Afrin Original 12-Hour Pump Mist Afrin Sinus 12-Hour Nasal Spray Afrin Sinus Spray Afrin Spray Pump Afrinol Aftate For Athlete's Foot Aerosol Spray Liquid Aftate For Athlete's Foot Aerosol Spray Powder Aftate for Athlete's Foot Gel Aftate For Athlete's Foot Sprinkle Powder Aftate For Athletes Foot Aftate For Jock Itch Aftate For Jock Itch Aerosol Spray Powder Aftate For Jock Itch Gel Aftate For Jock Itch Sprinkle Powder After Burn Double Strength Gel After Burn Double Strength Spray After Burn Gel After Burn Spray Agarol Plain Agarol Strawberry Agarol Vanilla Agenerase Aggrastat Aggrenox Agoral Marshmallow Agoral Raspberry Agrylin AH-chew AHF Airet AK-Beta AK-Chlor ophthalmic Ointment AK-Chlor ophthalmic Solution AK-Cide AK-Con AK-Dex AK-Dilate AK-Homatropine AK-Nefrin AK-Neo-Dex AK-Pentolate AK-Poly-Bac AK-Pred AK-Pro AK-Spore AK-Spore HC Ak-Spore HC Ophthalmic Suspension AK-Spore HC Otic AK-Spore Ointment AK-Spore ophthalmic Ointment AK-Spore ophthalmic Solution AK-Sulf AK-T-Caine AK-Taine AK-Tate AK-Tob AK-Tracin AK-Trol AK-Zol Akarpine AKBeta Akineton Akineton HCl Akne-Mycin AKPro AKTob Ala-Cort Ala-Scalp HP Alagesic Alamag Alamag Plus Alamast alatrofloxacin Alaxin Albalon Albalon Liquifilm albendazole Albenza Albert Docusate Albert Glyburide Albert Tiafen Albright's solution albuterol albuterol-ipratropium Alcaine Alclometasone alclometasone topical Alcomed Alcomed 2-60 Alcomicin Alconefrin Nasal Drops Alconefrin Nasal Spray Aldactazide Aldactone Aldara Aldoclor Aldoclor-150 Aldoclor-250 Aldomet Aldoril Aldoril 25 Aldoril D30 Aldoril D50 alendronate Alenic Alka Alenic Alka Extra Strength Aler-Dryl Alertec Alesse Alesse-21 Alesse-28 Aleve Aleve Caplet Aleve Cold and Sinus Alfacalcidol Alfenta Alfentanil Alferon N alfuzosin Alidrin alimemazine Alimentum AlitraQ alitretinoin topical Alka-Butazolidin Alka-Mints Alka-Seltzer Effervescent Pain Reliever Alka-Seltzer Effervescent Pain Reliever and Antacid Alka-Seltzer Plus Allergy Medicine Liqui-Gels Alka-Seltzer Plus Cold Alka-Seltzer Plus Cold and Cough Alka-Seltzer Plus Cold and Cough Medicine Liqui-Gels Alka-Seltzer Plus Cold Liquigel Alka-Seltzer Plus Cold Medicine Alka-Seltzer Plus Cold Medicine Liqui-Gels Alka-Seltzer Plus Flu & Body Aches Alka-Seltzer Plus Flu & Body Aches Medicine Liqui-Gels Alka-Seltzer Plus Night-Time Cold Alka-Seltzer Plus Night-Time Cold Liqui-Gels Alka-Seltzer Plus Night Time Effervescent Alka-Seltzer Plus Sinus Medicine Alka Butazolidin Alka Seltzer Plus Night Time Effervescent Alkeran Alkets Alkets Extra Strength Alkums All-Nite Cold All-Nite Cold Formula Allay Allegra Allegra-D Allent Aller-Chlor Aller-ChlorDecongestant Aller-Med Allercon Allercort Allerdryl Allerest Allerest 12-Hour Allerest 12-Hour Nasal Spray Allerest Eye Drops Allerest Headache Strength Allerest Maximum Strength Allerest No-Drowsiness Caplets Allerest No Drowsiness Allerest Sinus Allerest Sinus Pain Formula Caplets Allerfrim Allerfrin Allerfrin w/ codeine Allergen Allergia-C Allergy Allergy Drops Allerhist-1 Allerhist-D AllerMax Caplets Allerphed allopurinol Allovectin-7 Almacone Almacone II Almagel 200 Almay Anti-itch Lotion Almora Alocril Aloe Aloe Cort aloe vera topical Aloe Vesta Aloe Vesta 2 in 1 Antifungal Aloh-Gel Alomide Alophen Aloprim Alor 5 Alor 5/500 Alora alosetron Alpha-Baclofen Alpha-Tamoxifen alpha 1 -antitrypsin Alpha E alpha tocopherol Alpha1-antitrypsin Alphacaine Alphaderm Alphagan Alphamin Alphamul Alphanate AlphaNine SD Alphatrex Alphosyl alprazolam alprazolam Intensol alprostadil Alramucil Orange Alramucil Regular Alrex Alsoy Altace Altafed Altaflor Altanac Altarussin Altarussin DM Altarussin PE Altaryl Altatapp Alteplase AlternaGEL Altex Liquid Altex PSE Alti-Acyclovir Alti-Alprazolam Alti-Bromazepam Alti-Bromocriptine Alti-Clonazepam Alti-Doxycycline Alti-Minocycline Alti-MPA Alti-Sulfasalazine Alti-Triazolam Alti-Valproic Altorant Altropane-Spect Alu-Cap Alu-Tab Aludrox Alugel Alumadrine Alumina aluminum carbonate aluminum hydroxide Alupent Alurate amantadine Amaphen Amaryl ambenonium Ambenyl-D Decongestant Cough Formula Ambenyl Cough Ambi 10 Acne Medication Ambien AmBisome Ambophen Amcinonide amcinonide topical Amcort Amen Amerge Americaine Hemorrhoidal Americaine Topical Anesthetic First Aid Ointment Americaine Topical Anesthetic Spray Americet Amethocaine amethocaine butyl Amethocaine cinchocaine ethyl Amethocaine dyclocaine ethyl Amethocaine proxymetacaine amethopterin Amfebutamone Amfed T.D. Amfepramone Amgenal Cough Ami-Tex Ami-Tex L.A. Ami-tex PSE Amibid DM Amibid L.A. Amicar Amidal Amidate Amidrine Amigesic Amikacin Amikin Amilac Amilon amiloride amiloride-hydrochlorothiazide Amin-Aid Amino-Opti-C Amino-Opti-E aminobenzoate cinchocaine ethyl aminobenzoate lignocaine aminobenzoate lignocaine pramocaine aminobenzoate pramocaine Aminobenzoic Acid Aminobenzoic Acid Padimate Aminocaproic Acid Aminofen Aminofen Max aminolevulinic acid aminophylline aminosalicylate sodium amiodarone amithiozone Amitone amitriptyline amitriptyline-chlordiazepoxide amitriptyline-perphenazine Amlactin Amlexanox amlodipine amlodipine-benazepril ammonia ammoniated mercury ammonium chloride ammonium lactate topical Amobarbital amoxapine amoxicillin amoxicillin-clavulanate amoxicillin/clarithromycin/lansoprazole Amoxil Amoxil Pediatric Drops Ampakine amphetamine amphetamine-dextroamphetamine Amphocin Amphojel Amphojel 500 Amphojel Plus Amphotec amphotericin B amphotericin B topical ampicillin Ampicin amprenavir amyl nitrite Amytal Ana-Guard Anacin Anacin-3 Anacin-3 Extra Strength Anacin-3 Maximum Strength Anacin AF Anacin Caplets Anacin Extra Strength Anacin Maximum Strength Anacin P.M. Aspirin Free Anacin Tablets Anacin w/ codeine Anacobin Anadrol-50 Anaflex Anaflex 750 Anafranil anagrelide Analgesic Otic Anamine Anamine T.D. Anandron Anaplex Anaplex DM Anaplex HD Anapolon Anaprox Anaprox-D.S. Anaspaz anastrozole Anatuss Anatuss DM Anatuss L.A. Anbesol Baby Anbesol Baby Jel Anbesol Gel Anbesol
Load more

Recommended publications
  • (12) Patent Application Publication (10) Pub. No.: US 2008/0317805 A1 Mckay Et Al
    US 20080317805A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2008/0317805 A1 McKay et al. (43) Pub. Date: Dec. 25, 2008 (54) LOCALLY ADMINISTRATED LOW DOSES Publication Classification OF CORTICOSTEROIDS (51) Int. Cl. A6II 3/566 (2006.01) (76) Inventors: William F. McKay, Memphis, TN A6II 3/56 (2006.01) (US); John Myers Zanella, A6IR 9/00 (2006.01) Cordova, TN (US); Christopher M. A6IP 25/04 (2006.01) Hobot, Tonka Bay, MN (US) (52) U.S. Cl. .......... 424/422:514/169; 514/179; 514/180 (57) ABSTRACT Correspondence Address: This invention provides for using a locally delivered low dose Medtronic Spinal and Biologics of a corticosteroid to treat pain caused by any inflammatory Attn: Noreen Johnson - IP Legal Department disease including sciatica, herniated disc, Stenosis, mylopa 2600 Sofamor Danek Drive thy, low back pain, facet pain, osteoarthritis, rheumatoid Memphis, TN38132 (US) arthritis, osteolysis, tendonitis, carpal tunnel syndrome, or tarsal tunnel syndrome. More specifically, a locally delivered low dose of a corticosteroid can be released into the epidural (21) Appl. No.: 11/765,040 space, perineural space, or the foramenal space at or near the site of a patient's pain by a drug pump or a biodegradable drug (22) Filed: Jun. 19, 2007 depot. E Day 7 8 Day 14 El Day 21 3OO 2OO OO OO Control Dexamethasone DexamethasOne Dexamethasone Fuocinolone Fluocinolone Fuocinolone 2.0 ng/hr 1Ong/hr 50 ng/hr 0.0032ng/hr 0.016 ng/hr 0.08 ng/hr Patent Application Publication Dec. 25, 2008 Sheet 1 of 2 US 2008/0317805 A1 900 ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 80.0 - 7OO – 6OO - 5OO - E Day 7 EDay 14 40.0 - : El Day 21 2OO - OO = OO – Dexamethasone Dexamethasone Dexamethasone Fuocinolone Fluocinolone Fuocinolone 2.0 ng/hr 1Ong/hr 50 ng/hr O.OO32ng/hr O.016 ng/hr 0.08 nghr Patent Application Publication Dec.
    [Show full text]
  • May 23, 2007 Office of Pesticide Programs
    May 23, 2007 Office of Pesticide Programs (OPP) Regulatory Public Docket (7502P) Environmental Protection Agency 1200 Pennsylvania Ave., NW Washington, DC 20460-0001 RE: Insect Repellent-Sunscreen Combination Products [EPA-HQ-OPP-2007-0087] Beyond Pesticides appreciates the prudent contemplation of insect repellent-sunscreen combination products EPA proposed in the reregistration eligibility decision (RED) for N,N-diethyl-meta-toluamide (DEET). We also appreciate this opportunity to share our concerns over these products. Beyond Pesticides interest in this issue lies in our effort to restrict pesticide use in a manner that protects public health and the environment, and to advance alternatives that eliminate dependency on toxic chemicals. We oppose the reregistration of all DEET-sunscreen combination products for the following reasons: 1. DEET exposure can result in negative health effects. As the agency notes, the registration of DEET is unusual in that it is one of few residential-use pesticides that is applied directly to the skin. The result is that the public is being exposed to a pesticide that has the ability to cause in lab animals increased fetal loss, bone and skeleton abnormalities in the offspring of rabbits, birth defects in birds, reduction in size of the testes and degeneration, and has produced abnormal sperm with reduced motility. Additionally, the public is directly applying a chemical to their skin that is demonstrated to cross the placenta and move into fetal blood in humans, has the ability to cause mutagenicity and oxidative stress, can decrease sensory and motor skills, causes skin irritation and kills brain cells.1 2. Sunscreen exposure can result in negative health effects.
    [Show full text]
  • A Thesis Entitled Evaluating UVB and UVA Boosting Technologies For
    A Thesis entitled Evaluating UVB and UVA Boosting Technologies for Chemical and Physical Sunscreens by An Ngoc Hiep Huynh Submitted to the Graduate Faculty as partial fulfillment of the requirements for the Master of Science Degree in Pharmaceutical Sciences Industrial Pharmacy ___________________________________________ Gabriella Baki, Ph.D., Committee Chair ___________________________________________ Jerry Nesamony, Ph.D., Committee Member ___________________________________________ Matthew W. Liberatore, Ph.D., Committee Member ___________________________________________ Dr. Amanda C. Bryant-Friedrich, Dean College of Graduate Studies The University of Toledo May 2020 Copyright 2020 An Ngoc Hiep Huynh This document is copyrighted material. Under copyright law, no parts of this document may be reproduced without the expressed permission of the author. An Abstract of Evaluating UVB and UVA Boosting Technologies for Chemical and Physical Sunscreens by An Ngoc Hiep Huynh Submitted to the Graduate Faculty as partial fulfillment of the requirements for the Master of Science Degree in Pharmaceutical Sciences Industrial Pharmacy The University of Toledo May 2020 There are currently 14 organic and 2 inorganic UV filters approved in the United States. Due to coral reef safety concerns, octinoxate and oxybenzone have been banned in Hawaii, Key West, FL and the US Virgin Islands; and octocrylene is also being studied for its potential impact on coral reef safety, leaving 11 organic UV filters as viable options for sunscreen manufacturers – with limitations on their combination. Since consumers are always looking for sunscreens with high SPF and broad-spectrum protection, the need for UVB and UVA protection boosting technologies is greater than ever. In a preliminary study, about two dozen emollients were scanned for their SPF boosting capability with selected organic UV filters.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al
    US 200601 10428A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 de Juan et al. (43) Pub. Date: May 25, 2006 (54) METHODS AND DEVICES FOR THE Publication Classification TREATMENT OF OCULAR CONDITIONS (51) Int. Cl. (76) Inventors: Eugene de Juan, LaCanada, CA (US); A6F 2/00 (2006.01) Signe E. Varner, Los Angeles, CA (52) U.S. Cl. .............................................................. 424/427 (US); Laurie R. Lawin, New Brighton, MN (US) (57) ABSTRACT Correspondence Address: Featured is a method for instilling one or more bioactive SCOTT PRIBNOW agents into ocular tissue within an eye of a patient for the Kagan Binder, PLLC treatment of an ocular condition, the method comprising Suite 200 concurrently using at least two of the following bioactive 221 Main Street North agent delivery methods (A)-(C): Stillwater, MN 55082 (US) (A) implanting a Sustained release delivery device com (21) Appl. No.: 11/175,850 prising one or more bioactive agents in a posterior region of the eye so that it delivers the one or more (22) Filed: Jul. 5, 2005 bioactive agents into the vitreous humor of the eye; (B) instilling (e.g., injecting or implanting) one or more Related U.S. Application Data bioactive agents Subretinally; and (60) Provisional application No. 60/585,236, filed on Jul. (C) instilling (e.g., injecting or delivering by ocular ion 2, 2004. Provisional application No. 60/669,701, filed tophoresis) one or more bioactive agents into the Vit on Apr. 8, 2005. reous humor of the eye. Patent Application Publication May 25, 2006 Sheet 1 of 22 US 2006/0110428A1 R 2 2 C.6 Fig.
    [Show full text]
  • Sun Protection, Sunscreens and Vitamin D
    SunSun protection,protection, sunscreenssunscreens andand VitaminVitamin DD GPGP NationalNational ConferenceConference RotoruaRotorua EnergyEnergy EventsEvents CentreCentre JuneJune 20092009 Dr. Louise Reiche Dermatologist New Zealand Dermatological Society Incorporated MelanomaMelanoma SkinSkin cancercancer andand sunlightsunlight Exposure to UVR causes > 90% of skin cancers Skin cancer is commonest cancer in NZ >50,000 new cases per year ~300 deaths per year ~$33.4 NZ million per year International Agency for Research on Cancer. IARC Monographs on the evaluation of carcinogenic risks to humans. Solar ultraviolet radiation. Lyon: International Agency for Research on Cancer, 1992. Armstrong BK. How sun exposure causes skin cancer. In: Hill D, Elwood JM, English DR, Eds. Prevention of Skin Cancer. Dordrecht: Kluwer Academic Publishers, 2004. O’Dea D. The Costs of Skin Cancer to New Zealand. Wellington: Cancer Society of New Zealand, 2000. New Zealand Health Information Service. Cancer, New Registrations and Deaths. Wellington: New Zealand Health Information Service, 2004. MelanomaMelanoma 1842 new cases in 2002 328 directly attributable to severe sunburn (Sneyd and Cox 2006) Authors recommended, “to reduce burden of melanoma in NZ, need to prevent excessive sun exposure and (facilitate) early diagnosis” Whilst cancer overall is rare in adolescence, melanoma was commonest cancer MelanomaMelanoma NZ incidence and death rate among world highest 56.2/100,000 in European population of Auckland highest reported worldwide men
    [Show full text]
  • CANVAS Trial)
    Effectiveness research with Real World Data to support FDA’s regulatory decision making 1. RCT Details This section provides a high-level overview of the RCT that the described real-world evidence study is trying to replicate as closely as possible given the remaining limitations inherent in the healthcare databases. 1.1 Title Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes (CANVAS trial) 1.2 Intended aim(s) To compare canagliflozin to placebo on cardiovascular (CV) events including CV death, heart attack, and stroke in patients with type 2 diabetes mellitus (T2DM), whose diabetes is not well controlled at the beginning of the study and who have a history of CV events or have a high risk for CV events. 1.3 Primary endpoint for replication and RCT finding Major Adverse Cardiovascular Events, Including CV Death, Nonfatal Myocardial Infarction (MI), and Nonfatal Stroke 1.4 Required power for primary endpoint and noninferiority margin (if applicable) With 688 cardiovascular safety events recorded across the trials, there would be at least 90% power, at an alpha level of 0.05, to exclude an upper margin of the 95% confidence interval for the hazard ratio of 1.3. 1.5 Primary trial estimate targeted for replication HR = 0.86 (95% CI 0.75–0.97) comparing canagliflozin to placebo (Neal et al., 2017) 2. Person responsible for implementation of replication in Aetion Ajinkya Pawar, Ph.D. implemented the study design in the Aetion Evidence Platform. S/he is not responsible for the validity of the design and analytic choices. All implementation steps are recorded and the implementation history is archived in the platform.
    [Show full text]
  • Sunscreen Faqs
    Sunscreen FAQs What type of sunscreen should I use? There are two main types of sunscreen ingredients: physical sun blockers and chemical sunscreens. Physical sunscreens prevent ultraviolet light from reaching your skin, and contain either zinc oxide or titanium dioxide. Physical sunscreens protect against UVA and UVB damage. Physical sunscreens are preferred for patients with sensitive skin or children. Chemical sunscreens rely on an interaction between the sun and the chemical to protect your skin. Examples of such chemicals are avobenzone, octinoxate, homosalate, padimate O, and many others. Chemical sunscreens can protect against UVA, UVB, or both types of damage, depending on which ingredient is used. Read the label to ensure coverage for both UVA and UVB exposure. There are new ingredients being developed that take chemical sunscreens and stabilize them to prolong their activity (i.e., Helioplex, Mexoryl). Does the SPF really matter? In laboratory testing, there are minor differences between SPF 15 and SPF 30 or greater products. However, that data is based on using 1 oz. (30 gm.) of sunscreen for each full body application (the size of a shot glass). Most people use far less in real-life settings. For that reason, we recommend an SPF of at least 30. It is common to find good sunscreens with SPF ranging from 45-70. To maintain protection, reapply sunscreen every 1-3 hours, depending on sweating, water exposure, and sun intensity. Is sunscreen alone enough to protect my skin in the sun? In some cases, yes. However, if you are in the sun for longer periods on a regular basis (such as gardening, golfing, boating, sports), it may be better to add sun protective clothing or habits.
    [Show full text]
  • FDA Proposes Sunscreen Regulation Changes February 2019
    FDA Proposes Sunscreen Regulation Changes February 2019 The U.S. Food and Drug Administration (FDA) regulates sunscreens to ensure they meet safety and eectiveness standards. To improve the quality, safety, and eectiveness of sunscreens, FDA issued a proposed rule that describes updated proposed requirements for sunscreens. Given the recognized public health benets of sunscreen use, Americans should continue to use broad spectrum sunscreen with SPF 15 or higher with other sun protective measures as this important rulemaking eort moves forward. Highlights of FDA’s Proposals Sunscreen active ingredient safety and eectiveness Two ingredients (zinc oxide and titanium dioxide) are proposed to be safe and eective for sunscreen use and two (aminobenzoic acid (PABA) and trolamine salicylate) are 1 proposed as not safe and eective for sunscreen use. FDA proposes that it needs more safety information for the remaining 12 sunscreen ingredients (cinoxate, dioxybenzone, ensulizole, homosalate, meradimate, octinoxate, octisalate, octocrylene, padimate O, sulisobenzone, oxybenzone, avobenzone). New proposed sun protection factor Sunscreen dosage forms (SPF) and broad spectrum Sunscreen sprays, oils, lotions, creams, gels, butters, pastes, ointments, and sticks are requirements 2 proposed as safe and eective. FDA 3 • Raise the maximum proposed labeled SPF proposes that it needs more data for from SPF 50+ to SPF 60+ sunscreen powders. • Require any sunscreen SPF 15 or higher to be broad spectrum • Require for all broad spectrum products SPF 15 and above, as SPF increases, broad spectrum protection increases New proposed label requirements • Include alphabetical listing of active ingredients on the front panel • Require sunscreens with SPF below 15 to include “See Skin Cancer/Skin Aging alert” on the front panel 4 • Require font and placement changes to ensure SPF, broad spectrum, and water resistance statements stand out Sunscreen-insect repellent combination 5 products proposed not safe and eective www.fda.gov.
    [Show full text]
  • Chemical UVR Absorbers
    Chemical UVR Absorbers The names given in bold and used Diisopropyl methyl cinnamate Glyceryl ethyihexanoate dimethoxy- throughout this handbook are those of Empirical formula: cinnamate the International Nomenclature of C 6H22O2 Chemical names. Cosmetic Ingredients. Glyceryl octanoate dimethoxycinnamate; Chemical names: 2-propenoic acid, 3-(4-methoxyphenyl)-, 2-Propenoic acid, 3-12,4bis(1 diester with 1 ,3-dihydroxy-2-(2-ethyl-1 - methylethyphenyl-methyl ester; 2,5- oxohexyl)oxypropane diisopropyl methyl cinnamate _ lsoamyl-para-methoxycinnamate Ethyihexyl methoxycinnamate Empirical formula: Empirical formula: C151-12003 C 8H26O3 Chemical names: Cinnamates Chemical names: Amyl4-methoxycinnamate; isopentyl-4- 2-Ethylhexyl-4-methoxycin nam ate; methoxycinnamate; isopenlyl-para- Cinoxate 2-ethyl-hexyl-para-methoxycinnamate; methoxy-cinnamate; 3-(4-methoxyphenyl)- Empirical formula: para-methoxycinnamic acid, 2-ethylhexyl 2-propenoic acid, isopentyl ester Ci4HieO4 ester; 3-(4-methoxyphenyl)-2-propenoic acid, 2-ethylhexyl ester; octinoxate; octyl Trade names: Chemical names: methoxycinnamate; 2-propenoic acid, 3- Neo Heliopan type E 1000; Solarum AMC 2- Ethoxyothyl-para-methoxyci n nam ate; (4-methoxyphenyl)-2-ethylhexyl ester 2-propenoic acid, 3-(4-methoxyphery- para-A minobenzoic acids (PA BAs) 2-ethoxyethyl ester; 2-ethoxyethyl-4- Trade names: methoxycinnamate AEC Octyl Methoxycinnamate; Escalol Amyl dimethyl FABA 557; Eusolex 2292; Heliosol 3; Empirical formula: Trade names: Jeescreen OMC; Katoscreen OMC; Nec C14H21 NO2 Giv Tan F; Phiasol
    [Show full text]
  • Sunscreen Alternatives Sunscreen Alternatives
    Sunscreen Alternatives We all know that the sun can be damaging in many ways, but most sunscreens on the market have some questionable, if not dangerous, ingredients. Here are a few ways to play it safe in the sun without putting your health at risk. 1. Common Sense We all know it but often forget: Avoid midday (10 am-2 pm) sun as much as possible, stay in the shade when possible, wear sunglasses and sun hats, don’t stay out exposed for too long. 2. Cover Up! For short periods, especially early or late in the day, sunscreen may not be necessary. In fact, a little exposure every day is vital to keep our Vitamin D levels up! Instead cover the skin with lightweight, tightly woven clothing, and protect your face with a hat. Babies under 6 months especially need to be covered up, since they don’t yet have the protection of melanin. 3. Be a Label Reader Not all sunscreens are created equal. The “worst” chemicals to avoid include Oxybenzone and PABA/Padimate O. Some active ingredients that have been found less toxic include Titanium Dioxide and Zinc Oxide. 4. CaliCaliforniafornia Baby This very eco-friendly company makes three of the top ten sunscreens on Environmental Working Group’s “Low Health Hazard/Low Sun Hazard/Most Effective” list: the SPF 30+ No Fragrance Sunblock Stick, the SPF 30+ Everyday Sunblock Stick, and the SPF 30+ Everyday Lotion. They are widely available and reasonably priced. 5. Homemade There are many recipes out there for DIY sunscreen. Here’s one to try: In a double boiler over medium heat, mix 2 ½ oz sesame oil, 1 ½ oz coconut oil, and 1 ½ oz beeswax.
    [Show full text]
  • Annex VI, Last Update: 02/08/2021
    File creation date: 03/10/2021 Annex VI, Last update: 22/09/2021 LIST OF UV FILTERS ALLOWED IN COSMETIC PRODUCTS Substance identification Conditions Wording of Reference Maximum conditions of Product Type, concentration Update date number Chemical name / INN / XAN Name of Common Ingredients Glossary CAS Number EC Number Other use and body parts in ready for use warnings preparation 2 N,N,N-Trimethyl-4-(2-oxoborn-3-ylidenemethyl CAMPHOR BENZALKONIUM 52793-97-2 258-190-8 6% 15/10/2010 ) anilinium methyl sulphate METHOSULFATE 3 Benzoic acid, 2-hydroxy-, HOMOSALATE 118-56-9 204-260-8 10% 02/08/2021 3,3,5-trimethylcyclohexyl ester / Homosalate 4 2-Hydroxy-4-methoxybenzophenone / BENZOPHENONE-3 131-57-7 205-031-5 6% Reg (EU) Not more than Contains 02/08/2021 Oxybenzone 2017/238 of 10 0,5 % to protect Benzophenone-3 February 2017- product (1) date of formulation application from September 2017 6 2-Phenylbenzimidazole-5-sulphonic acid and its PHENYLBENZIMIDAZOLE SULFONIC 27503-81-7 248-502-0 8%(as acid) 08/03/2011 potassium, sodium and triethanolamine salts / ACID Ensulizole 7 3,3'-(1,4-Phenylenedimethylene) bis TEREPHTHALYLIDENE DICAMPHOR 92761-26-7 / 410-960-6 / - 10%(as acid) 26/10/2010 (7,7-dimethyl-2-oxobicyclo-[2.2.1] SULFONIC ACID 90457-82-2 hept-1-ylmethanesulfonic acid) and its salts / Ecamsule 8 1-(4-tert-Butylphenyl)-3-(4-methoxyphenyl) BUTYL 70356-09-1 274-581-6 5% 15/10/2010 propane-1,3-dione / Avobenzone METHOXYDIBENZOYLMETHANE 9 alpha-(2-Oxoborn-3-ylidene)toluene-4-sulphoni BENZYLIDENE CAMPHOR SULFONIC 56039-58-8 - 6%(as acid)
    [Show full text]
  • Should a Toxicological Risk Assessment of Ubiquitous Chemicals Be Done Using Data from Only One Source of Exposure?
    Mini Review Open Acc J of Toxicol Volume 4 Issue 2 - January 2020 Copyright © All rights are reserved by Di Nardo JC DOI: 10.19080/OAJT.2020.04.555633 Should a Toxicological Risk Assessment of Ubiquitous Chemicals Be Done Using Data from Only One Source of Exposure? Di Nardo JC1* and CA Downs2 1Retired Toxicologist, Vesuvius, USA 2Executive Director, Haereticus Environmental Laboratory, Clifford, USA Submission: January 09, 2020; Published: January 23, 2020 *Corresponding author: Di Nardo JC, Retired Toxicologist, Vesuvius, USA Keywords: Toxicological; Chemicals; Dioxybenzone; Octocrylene; Oxybenzone; Sulisobenzone Introduction consumers to believe that there is no further risk associated with the After much discussion and petitioning by several individuals, chemical. non-governmental organizations and scientists alike, the Food & Drug Administration (FDA) re-opened the sunscreen drug monograph Data on February 26, 2019 to review the safety of sunscreen actives In October of 2018 the Food & Drug Administration (FDA) banned considered Generally Recognized as Safe and Effective (GRASE) the chemical benzophenone from use in foods and/or in plastic food since 1978 [1]. After their review, the FDA concluded that the public wraps [3], because it was found to cause cancer in rodents according to a study conducted by the National Institute of Environmental safety of a dozen drug actives currently in use (several of which record “does not” currently contain sufficient data to support the Health Sciences in May 2007 [3]. In June 2012 the state of California are benzophenone based chemicals - avobenzone, dioxybenzone, added benzophenone to their Proposition 65 list recognizing it as octocrylene, oxybenzone and sulisobenzone) and, therefore, are a carcinogen and came to an agreement that a sunscreen product requesting industry to provide additional data (mainly toxicokinetics, should not contain any more that 50 parts per million [4].
    [Show full text]